• LAST PRICE
    0.8000
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    0.7800/ 20
  • Ask / Lots
    0.8300/ 24
  • Open / Previous Close
    0.0000 / 0.8000
  • Day Range
    ---
  • 52 Week Range
    Low 0.6801
    High 19.8700
  • Volume
    1,511
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Thursday's close: 0.7872
TimeVolumeSPRO
09:32 ET24300.8
09:34 ET10000.7999
09:39 ET4000.7887
09:43 ET128400.7973
09:45 ET2500.78
09:48 ET54000.7911
09:50 ET1000.7955
09:57 ET40680.7887
10:01 ET1000.7885
10:08 ET12000.7974
10:12 ET3000.7974
10:14 ET13140.7974
10:17 ET6890.7999
10:26 ET1000.7999
10:35 ET1000.7999
10:46 ET6000.7999
10:50 ET1250.789
10:51 ET1000.79445
10:57 ET1000.7999
11:00 ET2000.7944
11:02 ET1000.79495
11:08 ET4000.79495
11:11 ET4000.798
11:13 ET1000.79495
11:27 ET2000.79495
11:31 ET387530.79495
11:44 ET21000.79495
11:45 ET2000.79495
11:47 ET19000.7983
11:51 ET7000.7922
11:56 ET17000.81
11:58 ET14880.813
12:00 ET2000.8063
12:02 ET11050.8126
12:03 ET146630.8298
12:05 ET2000.8298
12:07 ET1000.8299
12:09 ET93830.83
12:14 ET6250.8002
12:16 ET1000.8213
12:18 ET29000.82
12:21 ET2000.8163
12:23 ET2000.8126
12:25 ET64900.804
12:36 ET2000.8095
12:38 ET9000.79945
12:41 ET1500.8
12:48 ET5270.795
12:50 ET10950.7822
12:52 ET1000.7819
12:54 ET1000.7776
12:59 ET130520.784
01:01 ET1000.7838
01:03 ET8500.7844
01:14 ET1000.7889
01:15 ET11000.7843
01:26 ET1000.7926
01:37 ET3000.78445
01:39 ET7500.785
01:42 ET1000.780325
01:44 ET1000.7889
01:46 ET8000.7889
01:48 ET2030.7852
01:53 ET1000.7853
02:00 ET1000.8134
02:02 ET1000.8017
02:08 ET1000.8017
02:11 ET4000.80175
02:15 ET1000.795925
02:20 ET4250.8134
02:24 ET1000.80175
02:26 ET1000.80175
02:27 ET1000.7901
02:29 ET3000.7957
02:31 ET78160.8041
02:33 ET4000.80205
02:36 ET1000.7907
02:38 ET14000.802
02:40 ET1000.7907
02:42 ET5000.7907
02:44 ET1000.7907
02:45 ET1000.7907
02:47 ET4170.7907
02:49 ET2000.7907
02:54 ET2000.8006
02:56 ET1000.7907
02:58 ET8000.7907
03:02 ET2000.80035
03:03 ET2000.7907
03:05 ET5150.81
03:07 ET2000.81
03:09 ET8000.80035
03:12 ET1000.7907
03:18 ET3000.7907
03:20 ET29980.81
03:21 ET1000.8004
03:23 ET2000.8005
03:25 ET5000.8005
03:27 ET2000.8005
03:30 ET1000.791
03:32 ET3000.81
03:34 ET1000.7911
03:36 ET1890.8005
03:38 ET4000.81
03:39 ET47000.7914
03:43 ET2000.8097
03:45 ET26300.80515
03:48 ET26000.8052
03:50 ET4000.79
03:52 ET2000.81
03:57 ET4000.815
03:59 ET60270.8
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesSPRO
Spero Therapeutics Inc
26.3M
-0.2x
---
United StatesAGLE
Aeglea Bio Therapeutics Inc
25.7M
-0.4x
---
United StatesOBSV
Obseva SA
23.2M
-0.4x
---
United StatesEMMA
Emmaus Life Sciences Inc
18.3M
-2.0x
---
United StatesVDRM
Viaderma Inc
9.4M
0.0x
---
United StatesTOMDF
Todos Medical Ltd
25.5M
-0.6x
---
As of 2022-08-08

Company Information

Spero Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on identifying, developing and commercializing novel treatments for MDR bacterial infections. Its lead product candidate, tebipenem HBr (tebipenem pivoxil hydrobromide), is developed as the oral carbapenem antibiotic for use in complicated urinary tract infections (cUTI) and acute pyelonephritis (AP). It is also developing SPR720 as a novel oral therapy product candidate for the treatment of rare, orphan pulmonary disease caused by non-tuberculous mycobacterial (NTM) infections. The Company also has an IV-administered next generation polymyxin product candidate, SPR206, developed from its potentiator platform, which is being developed to treat MDR Gram-negative infections in the hospital setting.

Contact Information

Headquarters
675 Massachusetts Ave Ste 14CAMBRIDGE, MA, United States 02139-3309
Phone
857-242-1600
Fax
302-655-5049

Executives

Independent Chairman of the Board
Milind Deshpande
President, Chief Executive Officer, Director
Ankit Mahadevia
Chief Financial Officer
Satyavrat Shukla
Chief Legal Officer
Tamara Joseph
Chief Development Officer
Timothy Keutzer

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$26.3M
Revenue (TTM)
$13.0M
Shares Outstanding
32.8M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
1.94
EPS
$-3.24
Book Value
$2.73
P/E Ratio
-0.2x
Price/Sales (TTM)
2.0
Price/Cash Flow (TTM)
---
Operating Margin
-758.35%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.